QRG CAPITAL MANAGEMENT, INC.

Position in LLY — ELI LILLY & Co

CIK 1996454 BERWYN, PA

Position in LLY

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$175,482,620

+$52,647,337 QoQ

Shares Held

146,305

+9.6% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

1.56%

of 13F equity value

Holder Rank

#283

of 4,605 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $606,823,434 across 15 Drug Manufacturers - General names. LLY ranks #1 (28.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	146,305	$175,482,620
2	JNJ	Johnson & Johnson	440,815	$111,953,785
3	ABBV	AbbVie Inc.	301,006	$75,745,149
4	MRK	Merck & Co., Inc.	428,993	$55,125,600
5	AMGN	Amgen Inc	98,650	$35,723,138
6	GILD	Gilead Sciences, Inc.	227,523	$28,745,255
7	NVS	Novartis AG	164,478	$25,776,992
8	PFE	Pfizer Inc	902,308	$21,727,576

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$175,482,620	146,305	+9.6%	Shares	Sole	2026-07-14
2026-03-31	$122,835,283	133,550	+17.8%	Shares	Sole	2026-04-27
2025-12-31	$121,880,544	113,411	+9.6%	Shares	Sole	2026-02-02
2025-09-30	$78,930,824	103,448	-20.1%	Shares	Sole	2025-10-28
2025-06-30	$100,892,229	129,427	+2.5%	Shares	Sole	2025-07-21
2025-03-31	$104,250,489	126,225	+6.2%	Shares	Sole	2025-04-17
2024-12-31	$91,752,972	118,851	-1.9%	Shares	Sole	2025-02-05
2024-09-30	$107,342,262	121,162	+1.7%	Shares	Sole	2024-10-30
2024-06-30	$107,904,999	119,182	+4.2%	Shares	Sole	2024-07-12
2024-03-31	$89,010,293	114,415	+0.3%	Shares	Sole	2024-05-07
2023-12-31	$66,491,935	114,067	+7.8%	Shares	Sole	2024-02-07
2023-09-30	$56,825,668	105,795	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.